Laboratory Dr. Krause & Kollegen MVZ GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Laboratory Dr. Krause & Kollegen MVZ GmbH - overview
Location
Kiel, -, Germany
Primary Industry
Healthcare
About
Laboratory Dr. Krause & Kollegen MVZ GmbH is a laboratory medicine provider in Germany, delivering diagnostic services that enhance patient care across multiple medical disciplines. Laboratory Dr. Krause & Kollegen MVZ GmbH specializes in laboratory diagnostics, offering a variety of services to healthcare providers and patients.
The firm is based in Kiel, Germany. The company's founder, Dr. Krause, has a history of involvement in medical laboratories, contributing to its establishment. There are no records of significant pivots or changes in business strategy, nor any mention of subsidiaries or parent companies.
Laboratory Dr. Krause & Kollegen MVZ GmbH provides a comprehensive range of laboratory analyses, including hematology, immunology, clinical chemistry, transfusion medicine, microbiology, and molecular diagnostics. These services are essential for accurate health condition diagnosis and monitoring, aiding healthcare providers in treatment decisions. The firm also offers convenient online lab order entry and mobile sample collection, catering to hospitals, clinics, and individual patients across Germany, including Kiel, Neumünster, Heide, Flensburg, and Sylt.
In the most recent fiscal year 2021, Laboratory Dr. Krause & Kollegen MVZ GmbH reported a revenue of EUR 40,899,641. 60 and an EBITDA of EUR 17,235,720. 90.
The company's revenue is primarily generated from diagnostic laboratory services to healthcare institutions and direct services to patients on a fee-for-service basis, ensuring accurate billing for services rendered. Future growth plans for Laboratory Dr. Krause & Kollegen MVZ GmbH include the development of new diagnostic products tailored to emerging healthcare needs, with specific launches anticipated in the upcoming year. The company aims to expand its operations into additional regions of Germany, particularly focusing on underserved areas by 2024.
Recent funding will be allocated to enhance laboratory technologies and expand the service offerings, thereby supporting the overarching goal of improving patient diagnostic experiences.
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories
Website
www.labor-krause.de
Total Amount Raised
Subscriber access only
Laboratory Dr. Krause & Kollegen MVZ GmbH - timeline of key events
Laboratory Dr. Krause & Kollegen MVZ GmbH - financials
| Fiscal Year Ended | Dec 31, 2009 | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income (USD) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (2,436.3) | - | - | - | - | - | - | - | - | - | - | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Laboratory Dr. Krause & Kollegen MVZ GmbH - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.